DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glauco…
Author: Business Wire
STAAR Surgical Announces Preliminary Fourth Quarter and Full Year 2020 Results
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today provided preliminary results for the fourth quarter and …
Alnylam Launches “Alnylam P5x25” Strategy for Planned Transition to a Top Five Biotech in Market Capitalization Over Next Five Years
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced its new 5-year strategy “Alnylam P5x25” focused on the Company’s planned transition to a top-5 biotech (measured by …
2020 On-site Mobile Clinic Achieves Excellent Air Quality and Professional Standards with STERIS and Emmes Optym Certification
BOSTON–(BUSINESS WIRE)–2020 On-site is the first mobile clinic in the industry to receive certifications from Emmes Optym and STERIS.
Rimsys Releases New Automated Unique Device Identification (UDI) Module for Its Holistic MedTech RIM Platform
PITTSBURGH–(BUSINESS WIRE)– #EUDAMED–Rimsys, a world-leading Regulatory Information Management (RIM) software platform for medical technology companies, announced the release of an innovative and automated solution to address the global Unique Devic…
Global Visual Impairment Market to Surpass US$ 8,130.3 Million by 2027, Says Coherent Market Insights (CMI)
SEATTLE–(BUSINESS WIRE)– #Blindness–North America is estimated to hold the largest market share in the global visual impairment market in 2020.
Ocular Therapeutix™ Promotes Michael Goldstein, MD, MBA, to President, Ophthalmology and Appoints Rabia Gurses Ozden, MD as Senior Vice President, Clinical Development
BEDFORD, Mass.–(BUSINESS WIRE)—- $OCUL #OCUTX–Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today a…
Aldeyra Therapeutics Announces Positive Top-Line Symptom and Sign Results from Run-In Cohort of Phase 3 TRANQUILITY Trial in Dry Eye Disease
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced positive top-line symptom, redness, and Schirmer’s test results from the run-in cohort of the Phase 3 TRANQUILITY clinical trial in patients with dry…
Kala Pharmaceuticals Announces Availability of EYSUVISTM for the Treatment of Dry Eye Disease and Provides Update on Development Pipeline
WATERTOWN, Mass.–(BUSINESS WIRE)–Kala Pharmaceuticals, Inc., (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced the launch of EYSUVIS…
Gemini Therapeutics Announces FDA Fast Track Designation Granted for GEM103 for the Treatment of Dry Age-Related Macular Degeneration (AMD) in Patients With Complement Factor H (CFH) Loss of Function Gene Variants
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Gemini Therapeutics, a clinical stage precision medicine company developing innovative treatments for genetically defined age-related macular degeneration (AMD), today announced that GEM103, the Company’s investigatio…
Alcon Announces Launch of AcrySof IQ Vivity, the First and Only Non-Diffractive Extended Depth of Focus Intraocular Lens in the U.S.
GENEVA–(BUSINESS WIRE)–Alcon Announces Launch of AcrySof IQ VivityTM, the First and Only Non-Diffractive Extended Depth of Focus Intraocular Lens in the U.S.
Alcon Announces Launch of AcrySof IQ Vivity, the First and Only Non-Diffractive Extended Depth of Focus Intraocular Lens in the U.S.
GENEVA–(BUSINESS WIRE)–Alcon Announces Launch of AcrySof IQ VivityTM, the First and Only Non-Diffractive Extended Depth of Focus Intraocular Lens in the U.S.
Aldeyra Therapeutics to Host Conference Call and Webcast to Discuss Top-Line Symptom, Redness, and Schirmer’s Test Results from Run-in Cohort of Phase 3 TRANQUILITY Trial
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) will host a conference call and webcast at 8:00 a.m. ET Thursday, January 7, 2021, to discuss top-line symptom, redness, and Schirmer’s test results from the run-in …
Noveome Biotherapeutics, Inc. Publishes Preclinical Results Demonstrating Neuroprotective Properties of ST266 Require Full Complement of Proteins
PITTSBURGH–(BUSINESS WIRE)–Noveome Biotherapeutics has published preclinical results evaluating the neuroprotective properties of its ST266 therapeutic in the journal PLOS ONE.
Global Laser-Assisted In-Situ Keratomileusis (LASIK) Surgery Markets, 2020-2024 – Increasing Medical Tourism for LASIK Surgery Driving Market Growth – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Laser-Assisted In-Situ Keratomileusis (LASIK) Surgery Market 2020-2024” report has been added to ResearchAndMarkets.com’s offering. The laser-assisted in-situ keratomileusis (LASIK) surgery market is poised to grow …
Keratoconus Epidemiology Forecast Report 2017-2030 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Keratoconus – Epidemiology Forecast to 2030” report has been added to ResearchAndMarkets.com’s offering. This ‘Keratoconus (KC) – Epidemiology Forecast – 2030’ report delivers an in-depth understanding of the disease, hist…
RMEI Medical Education, LLC – An International Leader in Patient-Centric, Practice-Based Continuing Education – Earns Interprofessional Joint Accreditation for the Healthcare Team
VOORHEES, N.J.–(BUSINESS WIRE)– #ACCME–RMEI Medical Education, LLC (RMEI) announced today that it has been granted Joint Accreditation™ for Interprofessional Continuing Education.
IVERIC bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
NEW YORK–(BUSINESS WIRE)–IVERIC bio granted non-statutory stock options to purchase an aggregate of 28,000 shares of common stock to two newly hired, non-executive employees.
Kopin Corporation Ships First Production Order of 720p Color OLED Microdisplays
WESTBOROUGH, Mass.–(BUSINESS WIRE)–Kopin® Corporation (NASDAQ: KOPN), a leading developer and provider of high-resolution microdisplays and display subassemblies for defense, enterprise, industrial, consumer and medical products, announced today it h…
Samsara Vision Appoints Three New Members to the Board of Directors
FAR HILLS, N.J.–(BUSINESS WIRE)– #AMD–Samsara Vision is pleased to announce the appointment of three new members to its Board of Directors.